{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-002224","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.106508+00:00","generated_at":"2026-06-04T00:52:54.527772+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Sonoma Pharmaceuticals files updated investor presentation highlighting HOCl product portfolio and global reach","bullets":["Presentation covers stabilized hypochlorous acid products for wound, eye, oral, nasal, and dermatological care.","Products sold in 55 countries directly or through distribution partners.","No new financial guidance, specific revenue figures, or material developments disclosed in the presentation.","Company continues to seek new distribution partners for global expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-002224","json":"https://secwatch.observer/filing/0001683168-24-002224.json","markdown":"https://secwatch.observer/filing/0001683168-24-002224.md","text":"https://secwatch.observer/filing/0001683168-24-002224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824002224/0001683168-24-002224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824002224/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:52:54.527772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}